▁British 8.5859375
▁Bi 8.046875
ote 1.814453125
ch 0.12213134765625
' 5.171875
s 0.00864410400390625
▁Mar 8.1328125
im 7.5859375
ast 0.634765625
at 0.0004062652587890625
▁Anti 7.21875
- 0.1263427734375
Can 1.8447265625
cer 0.0004303455352783203
▁Tre 3.97265625
at 0.0016307830810546875
ment 0.01543426513671875
▁to 3.642578125
▁be 1.052734375
▁Review 3.564453125
ed 0.0027980804443359375
▁at 3.734375
▁ES 6.19921875
MO 0.0023403167724609375
▁Conference 4.30078125
▁in 2.30859375
▁Vienna 2.892578125
<0x0A> 0.1990966796875
VI 8.828125
EN 0.1348876953125
NA 0.00420379638671875
▁- 5.03515625
▁Ex 8.5703125
c 1.6064453125
itement 2.845703125
▁is 1.0283203125
▁building 0.8828125
▁ahead 2.732421875
▁of 0.0031452178955078125
▁this 2.990234375
▁year 0.74267578125
' 0.1217041015625
s 0.0008306503295898438
▁European 0.544921875
▁Society 0.078857421875
▁for 0.140625
▁Medical 0.0022125244140625
▁On 0.00290679931640625
col 0.004150390625
ogy 8.153915405273438e-05
▁( 0.1551513671875
ES 0.0031871795654296875
MO 0.0002111196517944336
) 0.0246734619140625
▁conference 0.994140625
▁in 0.7314453125
▁Vienna 0.0272064208984375
, 0.8359375
▁as 2.396484375
▁British 1.3583984375
▁bi 1.2001953125
ote 0.014678955078125
ch 0.298583984375
▁company 0.900390625
, 2.166015625
▁Bi 3.544921875
ote 4.2734375
ch 0.470703125
Co 6.1328125
, 0.85888671875
▁prepar 1.2607421875
es 0.0012989044189453125
▁to 0.057373046875
▁present 0.9892578125
▁its 1.248046875
▁ground 3.255859375
bre 1.2685546875
aking 0.00019073486328125
▁anti 1.533203125
- 0.003753662109375
can 0.0291900634765625
cer 0.00024700164794921875
▁treatment 0.623046875
, 0.422119140625
▁Mar 0.82177734375
im 0.00399017333984375
ast 0.0002765655517578125
at 6.878376007080078e-05
. 1.4365234375
▁Exper 7.2265625
ts 0.01155853271484375
▁are 2.28125
▁eager 2.353515625
ly 0.69482421875
▁await 0.96337890625
ing 0.0013074874877929688
▁the 0.420166015625
▁review 6.31640625
▁of 0.402587890625
▁the 0.80029296875
▁drug 2.6328125
, 0.97900390625
▁which 0.375732421875
▁shows 5.0859375
▁promise 2.03125
▁for 2.07421875
▁revolution 6.7734375
izing 1.1318359375
▁cancer 1.443359375
▁treatment 0.326171875
. 0.80859375
<0x0A> 0.1099853515625
Mar 1.408203125
im 0.0020008087158203125
ast 0.0001819133758544922
at 0.00030994415283203125
, 1.6337890625
▁an 2.75
▁or 0.94091796875
al 0.323486328125
▁medic 3.21875
ation 0.0026378631591796875
, 0.55615234375
▁has 1.3505859375
▁been 0.69970703125
▁ha 4.02734375
iled 0.0001329183578491211
▁as 0.1029052734375
▁a 0.219482421875
▁potential 1.13671875
▁game 0.447998046875
- 0.1759033203125
ch 0.00089263916015625
anger 0.0149383544921875
▁in 0.268798828125
▁the 0.153564453125
▁battle 1.951171875
▁against 0.00428009033203125
▁cancer 0.046234130859375
. 0.55859375
▁It 1.5029296875
▁targets 3.388671875
▁the 1.3623046875
▁matrix 4.41796875
▁metal 0.0182342529296875
lo 0.0005240440368652344
prote 0.036468505859375
in 0.0299072265625
ase 0.319580078125
▁en 1.9892578125
zym 0.0007038116455078125
es 1.064453125
▁involved 4.57421875
▁in 0.003292083740234375
▁the 1.4111328125
▁spread 1.7509765625
▁and 2.130859375
▁growth 0.7265625
▁of 0.0004048347473144531
▁cancer 0.5166015625
▁cells 0.2274169921875
. 1.1396484375
▁The 1.7314453125
▁drug 0.779296875
' 2.939453125
s 2.658367156982422e-05
▁ability 2.185546875
▁to 0.00026345252990722656
▁in 1.3076171875
hib 0.0017452239990234375
it 0.0001354217529296875
▁these 0.42724609375
▁en 0.035186767578125
zym 1.3589859008789062e-05
es 0.0002799034118652344
▁has 0.59912109375
▁shown 2.224609375
▁significant 1.9853515625
▁potential 1.6376953125
▁in 0.52978515625
▁slow 3.095703125
ing 6.079673767089844e-05
▁or 1.5283203125
▁even 1.2138671875
▁hal 0.80615234375
ting 9.059906005859375e-06
▁cancer 2.07421875
▁pro 0.70654296875
gression 0.004150390625
▁in 1.5439453125
▁pre 2.716796875
cl 0.76123046875
in 1.5735626220703125e-05
ical 0.00026917457580566406
▁tri 1.64453125
als 2.2172927856445312e-05
. 0.1888427734375
▁E 9.59375
ager 1.37109375
▁to 0.71875
▁un 4.15234375
ve 2.169921875
il 6.878376007080078e-05
▁their 3.7578125
▁find 0.70654296875
ings 5.078315734863281e-05
, 0.6513671875
▁Bi 0.454833984375
ote 0.0015363693237304688
ch 0.00040078163146972656
Co 0.0048370361328125
▁secured 9.96875
▁a 0.227783203125
▁pr 4.27734375
estig 0.001743316650390625
ious 0.0001939535140991211
▁slot 1.9921875
▁at 0.70947265625
▁the 0.62060546875
▁ES 0.640625
MO 7.021427154541016e-05
▁conference 0.11309814453125
, 0.90478515625
▁which 1.7724609375
▁attract 4.75
s 0.00876617431640625
▁leading 2.203125
▁on 0.97314453125
colog 0.76611328125
ists 0.002674102783203125
▁and 0.82373046875
▁medical 2.638671875
▁profession 0.94091796875
als 3.325939178466797e-05
▁from 0.044769287109375
▁around 0.375244140625
▁the 0.0009636878967285156
▁world 0.126953125
. 0.0265960693359375
<0x0A> 0.10906982421875
Dr 3.861328125
. 0.155517578125
▁Em 6.58984375
ily 1.5263671875
▁Anderson 6.22265625
, 0.053192138671875
▁lead 2.884765625
▁research 0.67724609375
er 0.007640838623046875
▁at 1.130859375
▁Bi 0.064208984375
ote 0.00048041343688964844
ch 0.0001844167709350586
Co 0.0019550323486328125
, 0.095458984375
▁expressed 2.580078125
▁enthus 3.240234375
ias 0.00287628173828125
m 2.276897430419922e-05
▁about 1.0087890625
▁the 0.16748046875
▁up 1.162109375
coming 2.0384788513183594e-05
▁presentation 0.86181640625
. 0.53076171875
▁Spe 7.95703125
aking 0.00954437255859375
▁at 2.56640625
▁the 0.67822265625
▁company 1.923828125
' 0.060455322265625
s 6.639957427978516e-05
▁headquarters 0.669921875
▁in 0.09283447265625
▁London 0.9404296875
, 0.07049560546875
▁she 0.380859375
▁said 0.87353515625
, 0.221923828125
▁" 0.024658203125
Mar 2.447265625
im 0.0005459785461425781
ast 6.961822509765625e-05
at 0.0001437664031982422
▁has 0.73291015625
▁the 1.052734375
▁potential 0.0265045166015625
▁to 0.0007748603820800781
▁transform 1.8271484375
▁the 0.94921875
▁way 0.350830078125
▁we 0.189208984375
▁approach 2.978515625
▁cancer 0.050262451171875
▁treatment 0.06488037109375
. 0.1304931640625
▁Initial 9.46875
▁tests 4.609375
▁have 0.39892578125
▁shown 0.66943359375
▁incred 3.33203125
ibly 1.84375
▁prom 0.277587890625
ising 0.00014984607696533203
▁results 0.00913238525390625
, 0.1466064453125
▁and 0.135986328125
▁we 0.0631103515625
▁are 0.78515625
▁eager 1.7001953125
▁to 0.016082763671875
▁share 0.1771240234375
▁our 0.384033203125
▁find 0.033477783203125
ings 1.7881393432617188e-06
▁with 0.09429931640625
▁the 0.074462890625
▁medical 1.1142578125
▁community 0.01323699951171875
▁at 0.86181640625
▁ES 1.310546875
MO 7.11679458618164e-05
." 0.8994140625
<0x0A> 0.060028076171875
The 1.1279296875
▁significance 6.37890625
▁of 0.0010328292846679688
▁this 2.44921875
▁review 5.33984375
▁lies 5.44921875
▁in 0.179443359375
▁Mar 3.16796875
im 0.0008559226989746094
ast 0.00018084049224853516
at 0.0003833770751953125
' 0.00566864013671875
s 0.0002282857894897461
▁potential 0.59130859375
▁as 2.6875
▁a 0.22705078125
▁novel 3.390625
▁th 2.275390625
era 2.7894973754882812e-05
pe 1.0848045349121094e-05
ut 2.7298927307128906e-05
ic 0.0007772445678710938
▁option 1.1484375
▁for 0.384033203125
▁a 3.380859375
▁wide 0.8505859375
▁range 0.027069091796875
▁of 6.99758529663086e-05
▁can 0.48046875
cers 1.1324882507324219e-05
. 0.3759765625
▁Trad 4.96875
itionally 1.6630859375
, 0.005023956298828125
▁cancer 0.48388671875
▁treat 1.1259765625
ments 7.152557373046875e-06
▁have 0.341064453125
▁focused 0.810546875
▁on 0.052978515625
▁surg 3.896484375
ery 0.201904296875
, 0.08343505859375
▁radiation 0.86181640625
▁ther 1.896484375
apy 0.0007929801940917969
, 0.03704833984375
▁and 0.2041015625
▁chem 0.03570556640625
other 0.0004544258117675781
apy 0.0007429122924804688
. 0.751953125
▁While 1.6044921875
▁effective 2.111328125
, 1.8681640625
▁these 0.029937744140625
▁methods 1.384765625
▁often 0.88330078125
▁come 0.92626953125
▁with 0.00841522216796875
▁severe 1.68359375
▁side 0.0146026611328125
▁effects 0.0052642822265625
▁and 0.378173828125
▁limited 1.228515625
▁success 1.9951171875
▁rates 0.61474609375
, 2.578125
▁particularly 0.62939453125
▁in 0.52197265625
▁advanced 0.6328125
▁stages 0.9208984375
▁of 0.11737060546875
▁the 0.78515625
▁disease 0.0037441253662109375
. 0.0021820068359375
▁Mar 0.88232421875
im 0.0005044937133789062
ast 4.684925079345703e-05
at 0.00010943412780761719
' 1.6552734375
s 3.4928321838378906e-05
▁unique 1.5302734375
▁mechanism 0.445556640625
▁of 0.0254364013671875
▁action 0.0138092041015625
▁offers 1.1357421875
▁hope 2.669921875
▁for 0.09844970703125
▁more 2.091796875
▁target 0.3935546875
ed 0.00022280216217041016
▁and 0.330322265625
▁less 0.70361328125
▁invas 0.91015625
ive 3.4570693969726562e-06
▁treat 1.1982421875
ments 2.5391578674316406e-05
. 1.5810546875
<0x0A> 0.058380126953125
ES 3.578125
MO 0.0009431838989257812
▁conference 3.6015625
▁at 1.037109375
ten 0.0007786750793457031
de 2.586841583251953e-05
es 0.00042748451232910156
▁are 1.15234375
▁eager 1.15625
ly 0.6142578125
▁anticip 0.40966796875
ating 0.0001875162124633789
▁the 0.445068359375
▁session 6.69140625
▁led 6.52734375
▁by 0.0003025531768798828
▁Bi 1.8447265625
ote 0.0006422996520996094
ch 0.0001876354217529297
Co 0.001739501953125
' 1.99609375
s 0.00012195110321044922
▁team 1.43359375
. 0.9287109375
▁The 1.1650390625
▁event 3.80859375
▁is 1.3017578125
▁known 6.2578125
▁for 0.19677734375
▁show 1.2119140625
c 8.392333984375e-05
asing 7.152557373046875e-06
▁break 4.625
through 0.00011658668518066406
▁develop 3.62890625
ments 5.841255187988281e-06
▁in 0.1044921875
▁on 1.591796875
col 0.0157318115234375
ogy 1.9073486328125e-06
▁and 1.849609375
▁fost 6.76953125
ering 0.0066070556640625
▁collaboration 0.8564453125
▁between 0.9453125
▁research 1.068359375
ers 0.009918212890625
▁and 0.406494140625
▁industry 3.482421875
▁profession 1.423828125
als 1.0848045349121094e-05
. 0.03863525390625
▁With 1.6044921875
▁over 3.712890625
▁ 0.0208282470703125
3 1.4873046875
0 0.34765625
, 0.055908203125
0 0.0017061233520507812
0 6.4373016357421875e-06
0 6.401538848876953e-05
▁participants 1.751953125
▁expected 0.7529296875
▁to 1.1240234375
▁attend 0.0692138671875
, 0.34228515625
▁there 4.51171875
▁will 1.783203125
▁be 0.03302001953125
▁am 1.224609375
ple 1.6570091247558594e-05
▁opportunity 0.45751953125
▁for 0.2015380859375
▁scientific 4.92578125
▁exchange 0.6015625
▁and 0.1873779296875
▁networking 0.9365234375
. 0.10064697265625
<0x0A> 0.038330078125
However 5.65234375
, 9.822845458984375e-05
▁some 3.9921875
▁exper 1.0869140625
ts 2.2649765014648438e-06
▁are 1.6103515625
▁ur 4.21484375
ging 0.00010538101196289062
▁ca 0.01800537109375
ution 5.7220458984375e-06
▁until 3.76953125
▁the 1.1962890625
▁drug 2.755859375
' 1.53125
s 2.2292137145996094e-05
▁effic 1.1240234375
acy 1.2040138244628906e-05
▁and 0.63720703125
▁safety 0.0438232421875
▁have 1.126953125
▁been 0.0030918121337890625
▁thoroughly 1.4853515625
▁tested 1.4833984375
▁in 0.333740234375
▁human 2.119140625
▁tri 0.399658203125
als 2.384185791015625e-06
. 0.01242828369140625
▁Dr 3.09765625
. 0.0008463859558105469
▁Sarah 4.5546875
▁Mitchell 6.8046875
▁from 4.12109375
▁Vienna 10.0078125
▁General 3.083984375
▁Hospital 0.028961181640625
▁bel 5.14453125
ieves 7.62939453125e-06
▁that 0.301513671875
▁while 1.90234375
▁Mar 0.5830078125
im 0.00048422813415527344
ast 9.250640869140625e-05
at 0.00010597705841064453
' 1.6181640625
s 1.9311904907226562e-05
▁pre 2.26171875
cl 0.162841796875
in 4.076957702636719e-05
ical 5.459785461425781e-05
▁results 0.78369140625
▁are 0.14990234375
▁impress 3.8671875
ive 3.24249267578125e-05
, 0.0009369850158691406
▁further 1.7890625
▁research 0.9833984375
▁is 0.071044921875
▁needed 0.49658203125
▁to 0.47021484375
▁fully 3.197265625
▁understand 0.453369140625
▁its 0.188720703125
▁potential 0.173828125
▁benefits 2.693359375
▁and 0.053497314453125
▁draw 3.248046875
back 4.267692565917969e-05
s 3.802776336669922e-05
. 0.0615234375
▁" 1.38671875
It 1.9404296875
▁is 1.84765625
▁essential 1.6943359375
▁that 0.475830078125
▁we 0.5244140625
▁approach 1.880859375
▁this 2.087890625
▁new 1.6982421875
▁treatment 0.525390625
▁option 7.01171875
▁with 0.051513671875
▁an 1.640625
▁open 0.07269287109375
▁mind 0.01399993896484375
▁but 2.439453125
▁remain 5.01171875
▁w 5.51953125
ary 5.2094459533691406e-05
▁of 0.132568359375
▁any 2.298828125
▁un 2.08984375
for 1.9765625
ese 0.0004165172576904297
en 0.0012674331665039062
▁comp 2.49609375
lications 0.00011396408081054688
," 0.430419921875
▁she 0.037353515625
▁ad 4.1875
vised 0.002956390380859375
. 0.0243072509765625
<0x0A> 0.056365966796875
As 2.962890625
▁the 0.69873046875
▁ES 0.8505859375
MO 4.291534423828125e-05
▁conference 0.03204345703125
▁approaches 0.60791015625
, 0.00856781005859375
▁anticip 3.337890625
ation 8.153915405273438e-05
▁is 0.298095703125
▁building 0.54150390625
▁in 4.46484375
▁the 0.1087646484375
▁medical 1.0146484375
▁community 0.02642822265625
. 0.611328125
▁Bi 1.3564453125
ote 7.939338684082031e-05
ch 0.0002465248107910156
Co 0.0017709732055664062
' 0.392578125
s 5.888938903808594e-05
▁presentation 0.356201171875
▁on 3.451171875
▁Mar 0.020233154296875
im 0.0005774497985839844
ast 0.00011539459228515625
at 4.029273986816406e-05
▁is 0.7919921875
▁expected 1.27734375
▁to 0.00015175342559814453
▁be 1.607421875
▁one 1.0966796875
▁of 0.0004520416259765625
▁the 0.004695892333984375
▁highlight 0.6171875
s 0.0013141632080078125
▁of 0.07568359375
▁the 0.04754638671875
▁event 0.125244140625
, 0.80224609375
▁spark 4.390625
ing 7.534027099609375e-05
▁discuss 3.232421875
ions 5.960464477539062e-07
, 5.23828125
▁collabor 1.32421875
ations 0.00923919677734375
, 0.03033447265625
▁and 0.00023996829986572266
▁potential 2.458984375
▁adv 4.4296875
anc 0.30224609375
ements 2.1576881408691406e-05
▁in 0.043914794921875
▁cancer 0.6611328125
▁treatment 0.359619140625
. 0.0767822265625
▁The 2.447265625
▁outcome 5.08984375
▁of 0.080810546875
▁this 0.9658203125
▁review 0.468505859375
▁has 3.75390625
▁the 0.059112548828125
▁potential 0.045745849609375
▁to 0.0020389556884765625
▁shape 2.23046875
▁the 0.08160400390625
▁future 0.0743408203125
▁of 0.002399444580078125
▁cancer 1.1328125
▁th 6.2890625
era 0.00040030479431152344
pe 0.0005598068237304688
ut 3.5762786865234375e-05
ics 0.001880645751953125
, 0.81494140625
▁deliver 6.984375
ing 0.0025691986083984375
▁hope 0.56201171875
▁to 0.496337890625
▁millions 0.7939453125
▁world 3.005859375
wide 4.2319297790527344e-05
. 0.2113037109375
